The factors associated with a worse outcome of tocilizumab use in terms of hospital stay were: baseline situation at the start of tocilizumab treatment requiring IMV or supplemental oxygen, elevated levels of ferritin, GOT, GPT, CRP, LDH, lymphopenia, and low PAFI values. The gene discussed is GPT; the disease is lymphopenia.